Recently diagnosed with type 1 diabetes?

PARTICIPATION CHECKLIST You may be eligible if you: have been diagnosed with type 1 diabetes within the past 8 weeks; AND   are between the ages of 8-30 years old; AND   weigh at least 55 lbs (25 kg)       You may NOT be eligible if you:   are currently pregnant or breastfeeding; OR   have asthma; OR   have participated in another clinical trial within the past 6 weeks If you meet the above criteria and may wish to participate, contact the nearest clinical center for more information.

The AbATE trial is seeking volunteers to test teplizumab for its ability to slow or halt the progression of type 1 diabetes.

The AbATE Trial is for men and women between the ages of 8 and 30 who have been recently diagnosed with type 1 diabetes. Initial type 1 diabetes diagnosis must have taken place within the past 8 weeks. The study is not open to women who are pregnant or breastfeeding, those who have untreated heart failure or who have participated in another clinical trial within the past 6 weeks. Consult the checklist to the right to determine if you could be eligible.

If you believe you or a family member meet these criteria and may wish to participate, contact the nearest clinical center for more information.

About Participating

Before you decide whether to participate in any clinical research study, you should educate yourself to become familiar with how clinical trials work, what may or may not be expected of you and what the potential risks and benefits of participating may be.

A short guide to clinical trials and links to other resources are available by clicking here.

Click here to find out which of the clinical centers in the US and Canada is closest to you.

Toll-free study info:

1-877-STOP-T1D
(1-877-786-7813)